ID   CKAP2_HUMAN             Reviewed;         683 AA.
AC   Q8WWK9; A2BDE0; A5YM58; B4DR35; E9PD90; Q3KRA5; Q5VXB4; Q8IWV5; Q8IWV6;
AC   Q96FH9; Q9H012; Q9H0D0; Q9H988; Q9HC49; Q9NVG4;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   18-JUN-2025, entry version 170.
DE   RecName: Full=Cytoskeleton-associated protein 2;
DE   AltName: Full=CTCL tumor antigen se20-10;
DE   AltName: Full=Tumor- and microtubule-associated protein;
GN   Name=CKAP2 {ECO:0000312|HGNC:HGNC:1990};
GN   Synonyms=LB1 {ECO:0000312|EMBL:CAC17466.1}, TMAP
GN   {ECO:0000312|EMBL:AAL47212.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAC17466.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND VARIANT VAL-323.
RC   TISSUE=T-cell {ECO:0000312|EMBL:CAC17466.1};
RX   PubMed=9771967; DOI=10.1038/sj.onc.1202048;
RA   Maouche-Chretien L., Deleu N., Badoual C., Fraissignes P., Berger R.,
RA   Gaulard P., Romeo P.H., Leroy-Viard K.;
RT   "Identification of a novel cDNA, encoding a cytoskeletal associated
RT   protein, differentially expressed in diffuse large B-cell lymphomas.";
RL   Oncogene 17:1245-1251(1998).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAD22295.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=11234418;
RA   Udina I.G., Baranova A.V., Kompaniytsev A.A., Sulimova G.E.;
RT   "Evolutionarily-conserved gene CKAP2, located in region 13q14.3 of the
RT   human genome, is frequently rearranged in various tumors.";
RL   Genetika 37:120-123(2001).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAL47212.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), SUBCELLULAR LOCATION, AND
RP   INDUCTION.
RC   TISSUE=Cervix carcinoma {ECO:0000312|EMBL:AAL47212.1};
RX   PubMed=12942315; DOI=10.1007/s00432-003-0484-0;
RA   Bae C.-D., Sung Y.-S., Jeon S.-M., Suh Y., Yang H.-K., Kim Y.-I.,
RA   Park K.-H., Choi J., Ahn G., Park J.;
RT   "Up-regulation of cytoskeletal-associated protein 2 in primary human
RT   gastric adenocarcinomas.";
RL   J. Cancer Res. Clin. Oncol. 129:621-630(2003).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAB14345.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND VARIANT
RP   VAL-323.
RC   TISSUE=Teratocarcinoma {ECO:0000312|EMBL:BAB14345.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:AAH10901.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT VAL-323.
RC   TISSUE=Bone marrow {ECO:0000312|EMBL:AAH10901.1}, Cerebellum, and
RC   Testis {ECO:0000312|EMBL:AAI05807.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAG33675.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 38-683 (ISOFORM 1), AND VARIANTS LYS-236 AND
RP   VAL-323.
RC   TISSUE=Testis {ECO:0000312|EMBL:AAG33675.1};
RX   PubMed=11149944; DOI=10.1073/pnas.98.2.629;
RA   Eichmueller S., Usener D., Dummer R., Stein A., Thiel D., Schadendorf D.;
RT   "Serological detection of cutaneous T-cell lymphoma-associated antigens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:629-634(2001).
RN   [9] {ECO:0000305, ECO:0000312|EMBL:CAB66782.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 135-683 (ISOFORM 1), AND VARIANT
RP   VAL-323.
RC   TISSUE=Testis {ECO:0000312|EMBL:CAB66782.2};
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [10]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=17376772; DOI=10.1074/jbc.m701688200;
RA   Seki A., Fang G.;
RT   "CKAP2 is a spindle-associated protein degraded by APC/C-Cdh1 during
RT   mitotic exit.";
RL   J. Biol. Chem. 282:15103-15113(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-579; THR-582; SER-595;
RP   THR-596; THR-597; TYR-599 AND SER-602, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-597 AND SER-602, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-534; SER-595; THR-597 AND
RP   SER-602, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178 AND SER-190, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Possesses microtubule stabilizing properties. Involved in
CC       regulating aneuploidy, cell cycling, and cell death in a p53/TP53-
CC       dependent manner (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Associates with alpha- and beta-tubulins. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton,
CC       spindle. Cytoplasm, cytoskeleton, spindle pole. Note=Contrary to the
CC       ectopically expressed protein, endogenous CKAP2 does not colocalize
CC       with microtubules in G1, S and early G2. At late G2 and prophase after
CC       separation of duplicated centrosomes, colocalizes with gamma-tubulin
CC       and centrosome-proximal microtubules. From prometaphase through
CC       anaphase B, colocalizes with mitotic spindle poles and spindle
CC       microtubules. During cytokinesis, absent from midbody microtubules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1 {ECO:0000269|PubMed:11149944, ECO:0000269|PubMed:12942315,
CC       ECO:0000269|PubMed:9771967};
CC         IsoId=Q8WWK9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WWK9-4; Sequence=VSP_047100, VSP_047101, VSP_047102;
CC       Name=4;
CC         IsoId=Q8WWK9-6; Sequence=VSP_055686;
CC       Name=3;
CC         IsoId=Q8WWK9-5; Sequence=VSP_047100;
CC   -!- TISSUE SPECIFICITY: Abundant in testis, thymus, and in tumor derived
CC       cell lines, while barely detectable in liver, prostate, and kidney.
CC       {ECO:0000269|PubMed:9771967}.
CC   -!- DEVELOPMENTAL STAGE: Present at the G1/S boundary. Accumulates as cells
CC       progress from S to G2 into mitosis. Rapidly degraded during mitosis
CC       exit by CDH1-activated anaphase promoting complex/cyclosome (APC/C).
CC       {ECO:0000269|PubMed:17376772}.
CC   -!- INDUCTION: Up-regulated in primary human gastric cancers.
CC       {ECO:0000269|PubMed:12942315}.
CC   -!- SIMILARITY: Belongs to the CKAP2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG33675.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH10901.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI05807.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA91788.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y15758; CAC17466.1; -; mRNA.
DR   EMBL; AJ429398; CAD22295.1; -; Genomic_DNA.
DR   EMBL; AY062261; AAL47212.1; -; mRNA.
DR   EMBL; AY062262; AAL47213.1; -; mRNA.
DR   EMBL; AK001611; BAA91788.1; ALT_INIT; mRNA.
DR   EMBL; AK022982; BAB14345.1; -; mRNA.
DR   EMBL; AK299083; BAG61147.1; -; mRNA.
DR   EMBL; EF560732; ABQ59042.1; -; mRNA.
DR   EMBL; AL359513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010901; AAH10901.1; ALT_INIT; mRNA.
DR   EMBL; BC105806; AAI05807.1; ALT_SEQ; mRNA.
DR   EMBL; BC130296; AAI30297.1; -; mRNA.
DR   EMBL; AF177227; AAG33675.1; ALT_FRAME; mRNA.
DR   EMBL; AL136848; CAB66782.2; -; mRNA.
DR   CCDS; CCDS41893.1; -. [Q8WWK9-1]
DR   CCDS; CCDS66557.1; -. [Q8WWK9-6]
DR   CCDS; CCDS73578.1; -. [Q8WWK9-4]
DR   CCDS; CCDS9435.1; -. [Q8WWK9-5]
DR   RefSeq; NP_001091995.1; NM_001098525.3. [Q8WWK9-1]
DR   RefSeq; NP_001273615.1; NM_001286686.2. [Q8WWK9-6]
DR   RefSeq; NP_001273616.1; NM_001286687.2. [Q8WWK9-4]
DR   RefSeq; NP_060674.3; NM_018204.4. [Q8WWK9-5]
DR   AlphaFoldDB; Q8WWK9; -.
DR   BioGRID; 117755; 135.
DR   ELM; Q8WWK9; -.
DR   FunCoup; Q8WWK9; 1027.
DR   IntAct; Q8WWK9; 86.
DR   MINT; Q8WWK9; -.
DR   STRING; 9606.ENSP00000367276; -.
DR   GlyGen; Q8WWK9; 4 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (3 sites).
DR   iPTMnet; Q8WWK9; -.
DR   PhosphoSitePlus; Q8WWK9; -.
DR   SwissPalm; Q8WWK9; -.
DR   BioMuta; CKAP2; -.
DR   DMDM; 74751579; -.
DR   jPOST; Q8WWK9; -.
DR   MassIVE; Q8WWK9; -.
DR   PaxDb; 9606-ENSP00000367276; -.
DR   PeptideAtlas; Q8WWK9; -.
DR   ProteomicsDB; 19610; -.
DR   ProteomicsDB; 74895; -. [Q8WWK9-1]
DR   Pumba; Q8WWK9; -.
DR   Antibodypedia; 1993; 133 antibodies from 24 providers.
DR   DNASU; 26586; -.
DR   Ensembl; ENST00000258607.10; ENSP00000258607.5; ENSG00000136108.15. [Q8WWK9-5]
DR   Ensembl; ENST00000378034.7; ENSP00000367273.2; ENSG00000136108.15. [Q8WWK9-4]
DR   Ensembl; ENST00000378037.9; ENSP00000367276.4; ENSG00000136108.15. [Q8WWK9-1]
DR   Ensembl; ENST00000490903.5; ENSP00000417830.1; ENSG00000136108.15. [Q8WWK9-6]
DR   GeneID; 26586; -.
DR   KEGG; hsa:26586; -.
DR   MANE-Select; ENST00000258607.10; ENSP00000258607.5; NM_018204.5; NP_060674.3. [Q8WWK9-5]
DR   UCSC; uc001vgt.4; human. [Q8WWK9-1]
DR   AGR; HGNC:1990; -.
DR   CTD; 26586; -.
DR   DisGeNET; 26586; -.
DR   GeneCards; CKAP2; -.
DR   HGNC; HGNC:1990; CKAP2.
DR   HPA; ENSG00000136108; Tissue enhanced (bone).
DR   MIM; 611569; gene.
DR   neXtProt; NX_Q8WWK9; -.
DR   OpenTargets; ENSG00000136108; -.
DR   PharmGKB; PA26526; -.
DR   VEuPathDB; HostDB:ENSG00000136108; -.
DR   eggNOG; ENOG502RUSI; Eukaryota.
DR   GeneTree; ENSGT00530000063691; -.
DR   HOGENOM; CLU_026552_0_0_1; -.
DR   InParanoid; Q8WWK9; -.
DR   OMA; HEPEGQN; -.
DR   OrthoDB; 9945093at2759; -.
DR   PAN-GO; Q8WWK9; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q8WWK9; -.
DR   TreeFam; TF333003; -.
DR   PathwayCommons; Q8WWK9; -.
DR   SignaLink; Q8WWK9; -.
DR   SIGNOR; Q8WWK9; -.
DR   BioGRID-ORCS; 26586; 51 hits in 1166 CRISPR screens.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   ChiTaRS; CKAP2; human.
DR   GeneWiki; CKAP2; -.
DR   GenomeRNAi; 26586; -.
DR   Pharos; Q8WWK9; Tbio.
DR   PRO; PR:Q8WWK9; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q8WWK9; protein.
DR   Bgee; ENSG00000136108; Expressed in ventricular zone and 179 other cell types or tissues.
DR   ExpressionAtlas; Q8WWK9; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0036064; C:ciliary basal body; IDA:HPA.
DR   GO; GO:0005929; C:cilium; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0000281; P:mitotic cytokinesis; IGI:MGI.
DR   GO; GO:0007026; P:negative regulation of microtubule depolymerization; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IGI:MGI.
DR   InterPro; IPR029197; CKAP2_C.
DR   InterPro; IPR026165; CKAP2_fam.
DR   PANTHER; PTHR16076; CYTOSKELETON ASSOCIATED PROTEIN 2-RELATED; 1.
DR   PANTHER; PTHR16076:SF8; CYTOSKELETON-ASSOCIATED PROTEIN 2; 1.
DR   Pfam; PF15297; CKAP2_C; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Cell cycle; Cytoplasm; Cytoskeleton;
KW   Microtubule; Phosphoprotein; Proteomics identification; Reference proteome.
FT   CHAIN           1..683
FT                   /note="Cytoskeleton-associated protein 2"
FT                   /id="PRO_0000245774"
FT   REGION          1..28
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          153..175
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          214..236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          336..403
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        219..236
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        336..345
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..376
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         579
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         582
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         595
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         596
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         597
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   MOD_RES         599
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         602
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         1..51
FT                   /note="MSTPAVPQDLQLPPSQRAQSAFKEQRRQKLKEHLLRRKTLFAYKQENEMLS
FT                   -> ML (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055686"
FT   VAR_SEQ         53
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12942315,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047100"
FT   VAR_SEQ         494..495
FT                   /note="PI -> VR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12942315"
FT                   /id="VSP_047101"
FT   VAR_SEQ         496..683
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12942315"
FT                   /id="VSP_047102"
FT   VARIANT         236
FT                   /note="M -> K (in dbSNP:rs35975899)"
FT                   /evidence="ECO:0000269|PubMed:11149944"
FT                   /id="VAR_054018"
FT   VARIANT         323
FT                   /note="I -> V (in dbSNP:rs7335867)"
FT                   /evidence="ECO:0000269|PubMed:11149944,
FT                   ECO:0000269|PubMed:11230166, ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9771967"
FT                   /id="VAR_069359"
FT   CONFLICT        402
FT                   /note="P -> L (in Ref. 9; CAB66782)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        531
FT                   /note="K -> Q (in Ref. 4; BAA91788)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        531
FT                   /note="K -> R (in Ref. 4; BAB14345)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        559
FT                   /note="F -> L (in Ref. 4; BAB14345)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        577
FT                   /note="V -> A (in Ref. 4; BAB14345)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        643
FT                   /note="K -> R (in Ref. 4; BAA91788)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   683 AA;  76987 MW;  15287A7D860A4B23 CRC64;
     MSTPAVPQDL QLPPSQRAQS AFKEQRRQKL KEHLLRRKTL FAYKQENEML SSSRDQRVVT
     SEDQVQEGTK VLKLKTKMAD KENMKRPAES KNNTVVGKHC IPLKPSNELT NSTVVIDTHK
     PKDSNQTPHL LLTEDDPQSQ HMTLSQAFHL KNNSKKKQMT TEKQKQDANM PKKPVLGSYR
     GQIVQSKINS FRKPLQVKDE SSAATKKLSA TIPKATKPQP VNTSSVTVKS NRSSNMTATT
     KFVSTTSQNT QLVRPPIRSH HSNTRDTVKQ GISRTSANVT IRKGPHEKEL LQSKTALSSV
     KTSSSQGIIR NKTLSRSIAS EVIARPASLS NDKLMEKSEP VDQRRHTAGK AIVDSRSAQP
     KETSEERKAR LSEWKAGKGR VLKRPPNSVV TQHEPAGQNE KPVGSFWTTM AEEDEQRLFT
     EKVNNTFSEC LNLINEGCPK EDILVTLNDL IKNIPDAKKL VKYWICLALI EPITSPIENI
     IAIYEKAILA GAQPIEEMRH TIVDILTMKS QEKANLGENM EKSCASKEEV KEVSIEDTGV
     DVDPEKLEME SKLHRNLLFQ DCEKEQDNKT KDPTHDVKTP NTETRTSCLI KYNVSTTPYL
     QSVKKKVQFD GTNSAFKELK FLTPVRRSRR LQEKTSKLPD MLKDHYPCVS SLEQLTELGR
     ETDAFVCRPN AALCRVYYEA DTT
//
